1 |
BISSANTZ C, KUHN B, STAHL M. A medicinal chemist's guide to molecular interactions[J]. J. Med. Chem., 2010, 53 (14):5061-5084.
|
2 |
WANG W, SINGH S, ZENG D L, et al.. Antibody structure, instability, and formulation[J]. J. Pharm Sci., 2007, 96(1): 1-26.
|
3 |
BECK A, WURCH T, BAILLY C, et al.. Strategies and challenges for the next generation of therapeutic antibodies[J]. Nat. Rev. Immunol., 2010, 10(5):345-352.
|
4 |
吴梅,刘小云.生物质谱在蛋白-蛋白相互作用研究中的应用[J].生命的化学,2017,37(1):2-8.
|
5 |
FAINI M, STENGEL F, AEBERSOLD R, et al.. The evolving contribution of mass spectrometry to integrative structural biology[J]. J. Am. Soc. Mass Spectrom., 2016, 27(6): 966-974.
|
6 |
MA L, YANG F, ZHENG J. Application of fluorescence resonance energy transfer in protein studies[J]. J. Mol. Struct., 2017, 1077: 87-100.
|
7 |
STROTH N. A surface plasmon resonance-based method for monitoring interactions between G protein-coupled receptors and interacting proteins[J]. J. Biol. Methods, 2016,3(1): 1-9.
|
8 |
HOMOLA J. Surface plasmon resonance sensors for detection of chemical and biological species[J]. Chem. Rev., 2008, 108(2):462-493.
|
9 |
LUR M, HWANG Y C, LIU I J, et al.. Development of therapeutic antibodies for the treatment of diseases[J]. J. Biomed. Sci., 2020, 27(1): 1-27.
|
10 |
MILLER K E, KIM Y, HUH W K, et al.. Bimolecular fluorescence complementation (BiFC) analysis: advances and recent applications for genome-wide interaction studies[J]. J. Mol. Biol., 2015, 427(11): 2039-2055.
|
11 |
POLGE C, LENTZE N, AUERBACH D, et al.. Two-hybrid, a powerful tool for systems biology[J]. Int. J. Mol. Sci., 2009, 10(6): 2763-2788.
|
12 |
HAMDI A, COLAS P. Yeast two-hybrid methods and their applications in drug discovery[J]. Trends Pharmacol. Sci., 2012, 33(2): 109-118.
|
13 |
王婷,葛怀娜,郭宏.酵母双杂交技术应用进展[J].生物技术进展,2015,5(5):392-396.
|
14 |
FERRO E, TRABALZINI L. The yeast two-hybrid and related methods as powerful tools to study plant cell signalling[J]. Plant Mol. Biol., 2013, 83(4-5): 287-301.
|
15 |
DUNHAM W H, MULLIN M, GINGRAS A C. Affinity-purification coupled to mass spectrometry: basic principles and strategies[J]. Proteomics, 2012,12(10): 1576-1590.
|
16 |
MANN M. Functional and quantitative proteomics using SILAC[J]. Nat. Rev. Mol. Cell Biol., 2006,7(12):952-958.
|
17 |
VERMEULEN M, HUBNER N C, MANN M. High confidence determination of specific protein-protein interactions using quantitative mass spectrometry[J]. Curr. Opin. Biotechnol., 2008,19(4): 331-337.
|
18 |
TRINKLE-MULCAHY, BOULON S, LAM Y W, et al.. Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes[J]. J. Cell Biol., 2008,183(2): 223-239.
|
19 |
XU X, SONG Y, LI Y, et al.. The tandem affinity purification method: an efficient system for protein complex purification and protein interaction identification[J]. Protein Expr. Purif., 2010, 72(2):149-156.
|
20 |
ROUX K J, KIM D I, RAIDA M, et al.. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells[J]. J. Cell Biol., 2012, 196(6): 801-810.
|
21 |
SNIDER J, KOTLYAR M, SARAONET P, et al.. Fundamentals of protein interaction network mapping[J/OL]. Mol. Syst. Biol., 2015, 11(12):848[2021-08-26]. .
|
22 |
陈学明,刘姿,马亮.活细胞内临近标记技术BioID在蛋白质相互作用研究中的进展[J].生命的化学,2021,41(5):996-1002.
|
23 |
LEE J J, PARK Y S, LEE K J. Hydrogen-deuterium exchange mass spectrometry for determining protein structural changes in drug discovery[J]. Arch. Pharm. Res., 2015, 38(10):1737-1745.
|
24 |
PUCHADES C, KUKRER B, DIEFENBACH O, et al.. Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS[J/OL]. Sci. Rep., 2019,9(1):4735[2021-08-26]..
|
25 |
DENG B, LENTO C, WILSON D J. Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development-A review[J]. Anal. Chim. Acta., 2016, 940: 8-20.
|
26 |
KONERMANN L, RODRIGUEZ A D, SOWOLE M A. Type 1 and Type 2 scenarios in hydrogen exchange mass spectrometry studies on protein-ligand complexes[J]. Analyst, 2014, 139(23):6078-6087.
|
27 |
WEI H, MO J, TAO L, et al.. Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications[J]. Drug Discov. Today, 2014, 19(1):95-102.
|
28 |
ZHANG H, CUI W, GROSS M L. Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies[J]. FEBS Lett., 2014, 588(2):308-317.
|
29 |
ABBOTT W M, DAMSCHRODER M M, LOWE D C. Current approaches to fine mapping of antigen antibody interactions[J]. Immunology, 2014, 142(4):526-535.
|
30 |
PAN L Y, SALAS-SOLANO O, VALLIERE-DOUGLASS J F. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry[J]. Anal. Chem., 2014, 86(5):2657-2664.
|
31 |
HUANG R Y, KUHNE M, DESHPANDE S, et al.. Mapping binding epitopes of monoclonal antibodies targeting major histocompatibility complex class I chain related a (MICA) with hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry[J]. Anal. Bioanal. Chem., 2020,412(7):1693-1700.
|
32 |
MCKENZIE-COE A, SHORTT R, JONES L M. The making of a footprint in protein footprinting: a review in honor of Michael L. Gross [J]. Mass Spectrom. Rev., 2021, 40(3):177-200.
|
33 |
YANG D, FREGO L, LASARO M, et al.. Efficient qualitative and quantitative determination of antigen-induced immune responses[J]. J. Biol. Chem., 2016, 291(31): 16361-16374.
|
34 |
DOMINA M, CARICCIO V L, BENFATTO S, et al.. Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries[J]. PLoS ONE, 2016,11 (8): 1-17.
|
35 |
RAFALIK M, SPODZIEJA M, KOLODZIEJCZYK A S, et al.. The identification of discontinuous epitope in the human cystatin C-monoclonal antibody HCC3 complex[J]. J. Proteome., 2019, 191:58-67.
|
36 |
CALVARESI V, REDSTED A, NORAIS N, et al.. Hydrogen-Deuterium exchange mass spectrometry with integrated size-exclusion chromatography for analysis of complex protein samples[J]. Anal. Chem., 2021, 93(33): 11406-11414.
|
37 |
HUANG R Y, KUHNE M, DESHPANDE S, et al.. Mapping binding epitopes of monoclonal antibodies targeting major histocompatibility complex class I chain-related A (MICA) with hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry[J]. Anal. Bioanal. Chem., 2020, 412(7): 1693-1700.
|
38 |
BERESZCZAK J Z, ROSE R J, WATTS N R, et al.. Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids[J]. J. Am. Chem. Soc., 2013,135(17):6504-6512.
|
39 |
FERNANDEZ E, KOSE N, EDELING M A, et al.. Mouse and human monoclonal antibodies protect against infection by multiple genotypes of Japanese encepha-litis virus[J/OL]. MBio, 2018,9(1):e00008-18[2022-01-24]. .
|
40 |
SPERRY J B, SMITH C L, CAPARON M G, et al.. Mapping the protein-protein interface between a toxin and its cognate antitoxin from the bacterial pathogen Streptococcus pyogenes [J]. Biochemistry, 2011, 5(19):4038-4045.
|
41 |
樊盛博,吴妍洁,杨兵 等.蛋白质结构与相互作用研究新方法-交联质谱技术[J].生物化学与生物物理进展,2014,41(11):1109-1125.
|
42 |
CHAVEZ J D, LEE C F, CAUDAL A, et al.. Chemical crosslinking mass spectrometry analysis of protein conformations and super complexes in heart tissue[J]. Cell Syst., 2018, 6(1):136-141.
|
43 |
HUANG B X, KIM H Y, DASS C. Probing three-dimensional structure of bovine serum albumin by chemical cross-linking and mass spectrometry[J]. J. Am. Soc. Mass Spectrom., 2004,15(8):1237-1247.
|
44 |
KAAKE R M, WANG X, BURKE A, et al.. A new in vivo cross-linking mass spectrometry platform to define protein-protein interactions in living cells[J]. Mol. Cell Proteomics., 2014, 13(12): 3533-3543.
|
45 |
LIU F, RIJKERS D T, POST H, et al.. Proteome-wide profiling of protein assemblies by cross-linking mass spectrometry[J]. Nat. Methods, 2015, 12(12): 1179-1184.
|
46 |
XU W, BEEBE K, CHAVEZ J D, et al.. Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1[J/OL]. Nat. Commun., 2019, 10(1): 2574[2021-08-26]..
|
47 |
CHAVEZ J D, ENG J K. SCHWEPPE D K,et al.. A general method for targeted quantitative cross-linking mass spectrometry[J]. PLoS ONE, 2016, 11(12):1-14.
|
48 |
PIERSIMONI L, SINZ A. Cross-linking/mass spectrometry at the crossroads[J]. Anal. Bioanal. Chem., 2020, 412(24): 5981-5987.
|
49 |
LIU F, HECK A J. Interrogating the architecture of protein assemblies and protein interaction networks by cross-linking mass spectrometry[J]. Curr. Opin. Struct., Biol., 2015,35:100-108.
|
50 |
YU C, HUANG L. Cross-linking mass spectrometry: an emerging technology for interactomics and structural biology[J]. Anal. Chem., 2018, 90(1): 144-165.
|
51 |
COUROUBLE V V, DEY S K, YADAV R, et al.. Revealing the structural plasticity of SARS-CoV-2 nsp7 and nsp8 using structural proteomics[J]. J. Am. Soc. Mass Spectrom., 2021, 32(7): 1618-1630.
|
52 |
ZHANG M M, ADHIKARI J, BENO B R, et al.. An integrated approach for determining a protein-protein binding interface in solution and an evaluation of hydrogen-deuterium exchange kinetics for adjudicating candidate docking models[J]. Anal. Chem., 2019, 91(24): 15709-15717.
|
53 |
DE JONG L, BUNCHERD H, ROSEBOOM W, et al.. In-culture cross-linking of bacterial cells reveals large-scale dynamic protein-protein interactions at the peptide level[J]. J. Proteome Res., 2017, 16(7):2457-2471.
|
54 |
WALKER-GRAY R, STENGEL F, GOLD M G, et al.. Mechanisms for restraining cAMP-dependent protein kinase revealed by subunit quantitation and cross-linking approaches[J]. Proc. Natl. Acad. Sci. USA, 2017, 114(39):10414-10419.
|
55 |
LEITNER A, FAINI M, STENGEL F, et al.. Crosslinking and mass spectrometry: an integrated technology to understand the structure and function of molecular machines[J]. Trends Biochem. Sci., 2016, 41(1):20-32.
|